- Claris collects $118M to take eye drop into pivotal testing next yearClaris Bio has a fresh CEO, new board chair and $118 million for two pivotal trials to see if its eye drop can succeed in a blinding disease with no pharmaceutical treatment options. It's a ...Endpoints · 18m ago↗ source
- Anthony Fauci’s pandemic-era diary entriesNew data on American substance use, concerns of a global HIV resurgence, and more health news from Morning RoundsSTAT · 21m ago↗ source
- GSK to start three-year plan to save cash, takes £1.33B hit on cough trial failureGSK said Tuesday it is rolling out a three-year restructuring program designed to cut costs and streamline its focus on key advanced assets. The UK drugmaker said in its second-quarter earnings r…